Find clinical trials for COVID-19 in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections

Communicable Diseases

Coronavirus Infections

Post-Acute COVID-19 Syndrome

Human Influenza

Pneumonia

Syndrome

COVID-19 trials near London, England, GBR:

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

The Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS) study is a two-stage, open-label, randomised controlled -...

Enrolling

Covid19

Pneumonia

Drug: Ruxolitinib

Other: Standard of care

Phase 1, Phase 2

Imperial College London

London, United Kingdom

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V (PROTECT-V)

COVID-19 (SARS-CoV2 virus) was declared a global pandemic by the WHO on 11th March 2020. Currently there are no drugs proven to pre-...

Enrolling

Covid19

Drug: Placebo

Drug: Sotrovimab

Phase 2, Phase 3

NHS Foundation Trust

London, United Kingdom and 44 other locations

A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers (COVAXAER01)

This study will test the COVID-19 vaccine candidate AZD1222 to investigate its safety, tolerability and capability of boosting immu-...

Active, not recruiting

Covid19

SARS-CoV-2 Infection

Biological: 1x10^10 vp AZD1222

Biological: 5x10^9 vp AZD1222

Phase 1

Imperial College London

London, United Kingdom

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting

COVID-19

Biological: mRNA-1283.222

Biological: mRNA-1273.815

Phase 3

Moderna

London, United Kingdom and 217 other locations

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting

COVID-19, SARS-CoV-2

Biological: AZD3152 (Sub-study)

Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca

London, United Kingdom and 214 other locations

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years (COVID-19)

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting

COVID-19

Other: Placebo

Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)

Phase 2, Phase 3

Novavax

London, United Kingdom and 95 other locations

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting

SARS-CoV-2 Infection

Biological: Intramuscular vaccine

Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

London, United Kingdom and 90 other locations

A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

A multi-part study of ALG-097558 to evaluate safety, tolerability, pharmacokinetics and drug-drug interaction potential after single and multiple dos...

Active, not recruiting

COVID-19

Drug: ALG-097558 in solution formulation

Drug: Placebo

Phase 1

Aligos Therapeutics

London, United Kingdom

Dose, Safety and Pathogenicity of SARS-CoV-2 Omicron Virus (BA.5)

An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a SARS-CoV-2 Omicron Challenge Strain (BA.5) in Healthy Participants 18 to 30...

Not yet enrolling

SARS-CoV-2 Infection

Biological: SARS-CoV-2 omicron virus dose arm 2

Biological: SARS-CoV-2 omicron virus dose arm 1

Early Phase 1

Hvivo

London, United Kingdom

Anti-viral Action Against Type 1 Diabetes Autoimmunity

The study GPPAD-05 AVAnT1A is a phase 4 clinical trial intending to enroll 2252 children, who will be randomly assigned to receive COVID-19...

Enrolling

Diabetes Mellitus, Type 1

Drug: Sodium Chloride 0.9% Inj

Drug: Comirnaty Injectable Product

Phase 4

Technical University of Munich

Cambridge, United Kingdom and 7 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for COVID-19 in .css-epvm6{white-space:nowrap;}London, England

Related conditions:

COVID-19 trials near London, England, GBR:

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V (PROTECT-V)

A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers (COVAXAER01)

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years (COVID-19)

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

Dose, Safety and Pathogenicity of SARS-CoV-2 Omicron Virus (BA.5)

Anti-viral Action Against Type 1 Diabetes Autoimmunity

Find clinical trials for COVID-19 in London, England